That's great. What previous human studies because my understanding was that Frequency Therapeutics has only had two: the one on six future cochlear implant patients and the current clinical trial? Was there a trial with cadaver cochleas?Someone talked to Jeff Karp about it and in previous studies they found evidence for this happening. I'm confident in their success because of the success Novartis has had in functional hearing regeneration in living people. Novartis has successfully restored partial hearing in severely deaf people. Frequency Therapeutics' approach is waaayyyy better than Novartis so it is possible that this might help us out. Besides, I doubt that something that works in dead human cochleas and living mice cochleas would fail.
A lot of us have been closely watching different studies and research papers for months now. Within the 80+ parts of this thread, towards the end of it we've found more hope in Frequency Therapeutics than in any other place. If we are wrong, we are wrong. It seems like different people on this forum (not necessarily you) have snuffed our people's dreams because they hoped for a completely different treatment that ended up failing. It seems crazy and more detrimental to rob people of their hope, even if it is bizarre. The minute people on these forums lose something to look forward to, they lose hope on life altogether. Let's push forward with a neutral approach.
If Novartis has a drug that restored partial hearing, where is it in the clinical trial process?
I'm all for hope. I would benefit from a drug that restores hearing, even if it did not treat my tinnitus. But I like to keep my expectation timeline realistic. I want this drug to succeed, but I recognize that it first needs to go through the proper thorough clinical testing process.